- Home
- ILMN vs ERIE Comparison
ILMN vs ERIE Comparison
Compare ILMN & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- ERIE
- Stock Information
- Founded
- ILMN 1998
- ERIE 1925
- Country
- ILMN United States
- ERIE United States
- Employees
- ILMN N/A
- ERIE N/A
- Industry
- ILMN Medical Specialities
- ERIE Specialty Insurers
- Sector
- ILMN Health Care
- ERIE Finance
- Exchange
- ILMN Nasdaq
- ERIE Nasdaq
- Market Cap
- ILMN 16.9B
- ERIE 18.6B
- IPO Year
- ILMN 2000
- ERIE 1995
- Fundamental
- Price
- ILMN $94.78
- ERIE $360.85
- Analyst Decision
- ILMN Buy
- ERIE
- Analyst Count
- ILMN 17
- ERIE 0
- Target Price
- ILMN $127.00
- ERIE N/A
- AVG Volume (30 Days)
- ILMN 2.3M
- ERIE 146.2K
- Earning Date
- ILMN 07-31-2025
- ERIE 08-07-2025
- Dividend Yield
- ILMN N/A
- ERIE 1.50%
- EPS Growth
- ILMN N/A
- ERIE 17.80
- EPS
- ILMN 7.91
- ERIE 11.95
- Revenue
- ILMN $4,284,000,000.00
- ERIE $3,973,472,000.00
- Revenue This Year
- ILMN N/A
- ERIE $11.70
- Revenue Next Year
- ILMN $2.78
- ERIE $7.83
- P/E Ratio
- ILMN $11.99
- ERIE $30.39
- Revenue Growth
- ILMN N/A
- ERIE 12.00
- 52 Week Low
- ILMN $68.70
- ERIE $332.34
- 52 Week High
- ILMN $156.66
- ERIE $547.00
- Technical
- Relative Strength Index (RSI)
- ILMN 43.93
- ERIE 55.43
- Support Level
- ILMN $93.32
- ERIE $346.00
- Resistance Level
- ILMN $99.54
- ERIE $380.67
- Average True Range (ATR)
- ILMN 3.76
- ERIE 9.74
- MACD
- ILMN -1.57
- ERIE 0.36
- Stochastic Oscillator
- ILMN 13.77
- ERIE 42.83
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About ERIE Erie Indemnity Company
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.